Clinical Trial Update: Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial at the University of Chicago comparing cetuximab alone versus pemetrexed/cetuximab therapy for non-small cell lung cancer was terminated, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• ERBITUX (cetuximab)

Snippet

Sponsor: University of Chicago | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-03-31